Wang W, Hao X, Lv X, Li Y, Xing W, Chen T
Sci Rep. 2025; 15(1):8890.
PMID: 40087327
DOI: 10.1038/s41598-025-92827-7.
Liang H, Dong S, Fu W, Zhang S, Yu W, Dong F
Stem Cell Rev Rep. 2022; 18(6):2179-2194.
PMID: 35188601
DOI: 10.1007/s12015-022-10354-8.
Cheng H, Zheng Z, Cheng T
Protein Cell. 2019; 11(1):34-44.
PMID: 31201709
PMC: 6949320.
DOI: 10.1007/s13238-019-0633-0.
Nguyen N, Luo Y, Fujita M
Expert Rev Dermatol. 2016; 8(2):111-113.
PMID: 26877760
PMC: 4749134.
DOI: 10.1586/edm.13.2.
Fatima F, Nawaz M
Chin J Cancer. 2015; 34(12):541-53.
PMID: 26369565
PMC: 4593342.
DOI: 10.1186/s40880-015-0051-5.
Identification of cancer stem cells and a strategy for their elimination.
Dolgova E, Alyamkina E, Efremov Y, Nikolin V, Popova N, Tyrinova T
Cancer Biol Ther. 2014; 15(10):1378-94.
PMID: 25117082
PMC: 4130731.
DOI: 10.4161/cbt.29854.
Targeting acute myeloid leukemia stem cells: a review and principles for the development of clinical trials.
Pollyea D, Gutman J, Gore L, Smith C, Jordan C
Haematologica. 2014; 99(8):1277-84.
PMID: 25082785
PMC: 4116825.
DOI: 10.3324/haematol.2013.085209.
Colon Cancer Stem Cells: Bench-to-Bedside-New Therapeutical Approaches in Clinical Oncology for Disease Breakdown.
Di Franco S, Mancuso P, Benfante A, Spina M, Iovino F, Dieli F
Cancers (Basel). 2013; 3(2):1957-74.
PMID: 24212791
PMC: 3757399.
DOI: 10.3390/cancers3021957.
Drug Resistant Breast Cancer Cell Line Displays Cancer Stem Cell Phenotype and Responds Sensitively to Epigenetic Drug SAHA.
Lu S, Labhasetwar V
Drug Deliv Transl Res. 2013; 3(2):183-94.
PMID: 23543868
PMC: 3608528.
DOI: 10.1007/s13346-012-0113-z.
The differential expression pattern of the BMI-1, SALL4 and ABCA3 genes in myeloid leukemia.
Shen Q, Liu S, Hu J, Chen S, Yang L, Li B
Cancer Cell Int. 2012; 12(1):42.
PMID: 23067006
PMC: 3538712.
DOI: 10.1186/1475-2867-12-42.
The biology of cancer stem cells and its clinical implication in hepatocellular carcinoma.
Yoon S
Gut Liver. 2012; 6(1):29-40.
PMID: 22375168
PMC: 3286736.
DOI: 10.5009/gnl.2012.6.1.29.
25 years of epidermal stem cell research.
Ghadially R
J Invest Dermatol. 2011; 132(3 Pt 2):797-810.
PMID: 22205306
PMC: 3998762.
DOI: 10.1038/jid.2011.434.
Targeting breast cancer stem cells.
McDermott S, Wicha M
Mol Oncol. 2010; 4(5):404-19.
PMID: 20599450
PMC: 3023958.
DOI: 10.1016/j.molonc.2010.06.005.
Reduced c-Myb activity compromises HSCs and leads to a myeloproliferation with a novel stem cell basis.
Garcia P, Clarke M, Vegiopoulos A, Berlanga O, Camelo A, Lorvellec M
EMBO J. 2009; 28(10):1492-504.
PMID: 19360001
PMC: 2688541.
DOI: 10.1038/emboj.2009.97.
SALL4 is a key regulator of survival and apoptosis in human leukemic cells.
Yang J, Chai L, Gao C, Fowles T, Alipio Z, Dang H
Blood. 2008; 112(3):805-13.
PMID: 18487508
PMC: 2481537.
DOI: 10.1182/blood-2007-11-126326.
Cancer stem cells: the lessons from pre-cancerous stem cells.
Gao J
J Cell Mol Med. 2007; 12(1):67-96.
PMID: 18053092
PMC: 3823473.
DOI: 10.1111/j.1582-4934.2007.00170.x.
Stem cell origin of death-from-cancer phenotypes of human prostate and breast cancers.
Glinsky G
Stem Cell Rev. 2007; 3(1):79-93.
PMID: 17873385
DOI: 10.1007/s12015-007-0011-9.
The emerging picture of the mouse mammary stem cell.
Vaillant F, Asselin-Labat M, Shackleton M, Lindeman G, Visvader J
Stem Cell Rev. 2007; 3(2):114-23.
PMID: 17873344
DOI: 10.1007/s12015-007-0018-2.
Ontogenic growth of the haemopoietic stem cell pool in humans.
Dingli D, Pacheco J
Proc Biol Sci. 2007; 274(1624):2497-2501.
PMID: 17686727
PMC: 2274981.
DOI: 10.1098/rspb.2007.0780.
Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells.
Yang J, Chai L, Liu F, Fink L, Lin P, Silberstein L
Proc Natl Acad Sci U S A. 2007; 104(25):10494-9.
PMID: 17557835
PMC: 1965541.
DOI: 10.1073/pnas.0704001104.
